Rapid generation of potent antibodies by autonomous hypermutation in yeast
- 24 June 2021
- journal article
- research article
- Published by Springer Nature in Nature Chemical Biology
- Vol. 17 (10) , 1057-1064
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (T32GM007753, T32GM007753, T32GM007753, R01AI146779, 1R01CA260415, DP5OD021345, 1R01CA260415, 1R35GM136297, 1R01CA260415)
- Massachusetts Consortium on Pathogenesis Readiness
- Vallee Foundation (Scholars Award)
- Gordon and Betty Moore Foundation (Inventors Fellowship)
- UC | University of California, Irvine (COVID-19 Basic, Translational and Clinical Research Fund)
This publication has 54 references indexed in Scilit:
- Systems for in vivo hypermutation: a quest for scale and depth in directed evolutionCurrent Opinion in Chemical Biology, 2021
- Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variantCell, 2021
- Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UKJournal of Infection, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021
- Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 BindingCell, 2020
- Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic NanobodyCell, 2019
- Scalable, Continuous Evolution of Genes at Mutation Rates above Genomic Error ThresholdsCell, 2018
- iDISCO: A Simple, Rapid Method to Immunolabel Large Tissue Samples for Volume ImagingCell, 2014
- Engineering antibodies by yeast displayArchives of Biochemistry and Biophysics, 2012
- Directed evolution of a secretory leader for the improved expression of heterologous proteins and full‐length antibodies in Saccharomyces cerevisiaeBiotechnology and Bioengineering, 2009